04.11.2012 • News

Applikon, Thermo Fisher Sign Bilateral Supply Agreement

Applikon Biotechnology, a global supplier of bioreactor control systems to the biopharma market, today announced the signing of a bilateral supply agreement with Thermo Fisher Scientific.

As part of the agreement, Thermo Fisher and Applikon have developed an integrated solution that combines the Thermo Scientific HyClone Single-Use Bioreactor (S.U.B.) with the Applikon ez- and i-Control systems.

Thermo Scientific will resell this solution under the Thermo Scientific HyPerforma product suite. Applikon will resell the S.U.B. as a integrated solution.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read